CTRI/2017/05/008627
Completed
Phase 4
Etiopathological study of Dyslipidemia and role of Mustadi Ghana and Pathyapalana in its management ââ?¬â?? Single blind Randomized Comparative Clinical Trial
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University0 sites54 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University
- Enrollment
- 54
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients having deranged lipid profile with or without having any symptoms of Sthaulaya/Santarpanjanyavyadhi i.e.Sharirabharvriddhi(overweight)
- •Alasya(fatigue)
- •Gurugatrata(heaviness in body)
- •Aayase shwaskrichhta(dyspnoea)
- •Atikshudha(excessive hunger)
- •Atipipasa(excessive thirst)
- •Swedahikya(excessive perspiration at normal teperature in normal condition)
- •Daurgandhya(bad odor due to perspiration)
- •Daurbalya(weakness)
- •Snigdhangata(oily luster of body)
Exclusion Criteria
- •Age less than 30 years and more than 60 years
- •tuberculosis
- •IHD patients with history of MI within past 6 months
- •hypothyroidism
- •drug induced hyperlipidemia
- •pregnant and lactating woman
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)JPRN-UMIN000051501TOKYO CENTER CLINIC180
Completed
Not Applicable
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.DyslipidemiaJPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350
Completed
Not Applicable
Study in patients of increased blood cholesterolHealth Condition 1: null- patients of hypercholesterolemia eligible for statin therapyCTRI/2016/11/007486All India Institute of Medical Sciences AIIMS
Completed
Not Applicable
Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acidsdyslipidemiaJPRN-UMIN000026984Kobe University Graduate School of Medicine40
Completed
Not Applicable
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)Health Condition 1: null- DyslipidemiaHealth Condition 2: E781- Pure hyperglyceridemiaCTRI/2013/02/003429Merck Sharp and Dohme850